Karen Knudsen: Thankful for the incredible partnership with AstraZeneca as we improve lives, together
David Fredrickson, Executive Vice-President of the Oncology Business at AstraZeneca, shared a post on LinkedIn:
“This week my colleagues and I visited the AstraZeneca Hope Lodge in Boston, a place offering a free home away from home for cancer patients and their caregivers.
It was deeply rewarding to hear and see how this community is providing much-needed support for people while they are receiving cancer care in Boston.
It was also emotional to witness two patients ring the bell, signifying the end of their therapy, and to meet one of the first women enrolled in one of our studies.
As part of our long-standing relationship with the American Cancer Society, AstraZeneca funded the development of this Hope Lodge, which opened in 2008, to support our commitment to ensuring equitable access to cancer care services.
We’ve continued to support the Lodge in many ways with a goal to make the experience of those staying there a bright spot during an incredibly difficult time. It’s important to remember that holistic cancer care includes more than just medicines and a treatment plan.
Things like a convenient place to stay during treatment can also help enable more equitable access to cancer care and may even improve outcomes. It’s visits like this that remind us why we do the work we do.
Thank you so much for hosting us Karen Knudsen, Mark Goldberg, Jennifer Lombardo, Louise Santosuosso, Chris Thomas, and Michael Duff.”
Karen Knudsen shared this post, adding:
“Very special night, serving dinner for cancer patients and their families at our AstraZeneca Hope Lodge in Boston— where patients stay without charge during care— with the AstraZeneca CEO and executive team.
So thankful for the incredible partnership as we improve lives, together.”
Sources: Karen Knudsen/LinkedIn and David Fredrickson/LinkedIn
Karen E. Knudsen, MBA PhD, is the CEO of both the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN).
Dr. Knudsen is known for her practice-changing research in prostate cancer, which has contributed to new, effective cancer treatments.
She also holds several thought leadership roles, including advisory positions with the National Cancer Institute and the American Society for Clinical Oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023